0.8025
price down icon2.73%   -0.0225
after-market 시간 외 거래: .81 0.0075 +0.93%
loading
전일 마감가:
$0.825
열려 있는:
$0.83
하루 거래량:
871.46K
Relative Volume:
1.41
시가총액:
$32.10M
수익:
-
순이익/손실:
$-35.58M
주가수익비율:
-0.3028
EPS:
-2.65
순현금흐름:
$-42.82M
1주 성능:
-12.45%
1개월 성능:
-22.09%
6개월 성능:
-47.20%
1년 성능:
-35.80%
1일 변동 폭
Value
$0.8005
$0.8399
1주일 범위
Value
$0.8005
$0.92
52주 변동 폭
Value
$0.8005
$3.02

Iterum Therapeutics Plc Stock (ITRM) Company Profile

Name
명칭
Iterum Therapeutics Plc
Name
전화
(872) 225-6077
Name
주소
3 DUBLIN LANDINGS, DUBLIN 1
Name
직원
9
Name
트위터
Name
다음 수익 날짜
2025-02-07
Name
최신 SEC 제출 서류
Name
ITRM's Discussions on Twitter

ITRM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ITRM
Iterum Therapeutics Plc
0.8025 33.00M 0 -35.58M -42.82M -2.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-05-28 업그레이드 Gabelli & Co Sell → Hold
2021-03-15 업그레이드 H.C. Wainwright Neutral → Buy
2020-06-02 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-01-21 다운그레이드 Gabelli & Co Buy → Sell
2019-12-11 다운그레이드 SVB Leerink Outperform → Mkt Perform
2019-06-21 개시 H.C. Wainwright Buy
모두보기

Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스

pulisher
Jul 25, 2025

Iterum Therapeutics plc Stock Analysis and ForecastFree Stock Market Trend Analysis - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Iterum Therapeutics plc a good long term investmentSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Iterum Therapeutics plc stock priceConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Iterum Therapeutics Plc (ITRM) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Iterum Therapeutics plc stockHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Iterum Therapeutics plc stock attracts strong analyst attentionMassive Profit Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Iterum Therapeutics plc stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Iterum Therapeutics plc stock performs during market volatilityFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

OneDigital Investment Advisors LLC Invests $124,000 in Iterum Therapeutics PLC (NASDAQ:ITRM) - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

Iterum Therapeutics (NASDAQ:ITRM) Trading Down 4.2% – Here’s What Happened - Defense World

Jul 08, 2025
pulisher
Jul 05, 2025

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 05, 2025
pulisher
Jun 30, 2025

Iterum Strengthens Launch Strategy: 30-Year Pharma Veteran Christine Coyne to Lead ORLYNVAH Commercialization - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - Yahoo Finance

Jun 30, 2025
pulisher
Jun 29, 2025

Certain Options of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Certain Ordinary Shares of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025
pulisher
Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Resul - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Results | ITRM Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

New Antibiotic Shows Promise Against Drug-Resistant UTIs: NEJM Evidence Reveals 9.2% Multi-Resistance Rate - Stock Titan

Jun 25, 2025
pulisher
Jun 17, 2025

Transcript : Iterum Therapeutics plcSpecial Call - MarketScreener

Jun 17, 2025
pulisher
Jun 14, 2025

Research Analysts Set Expectations for ITRM FY2026 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $45,000 in Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships - pharmaphorum

Jun 13, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Acquires Shares of 21,207 Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics (ITRM) Partners with EVERSANA for U.S. Launc - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics announces partnership with EVERSANA - PharmaLive

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Iterum Therapeutics Announces Partnership for Commercialization Services - Yahoo Finance

Jun 11, 2025
pulisher
May 19, 2025

Pfizer grants Iterum payment extension for FDA-approved antibiotic By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Pfizer grants Iterum payment extension for FDA-approved antibiotic - Investing.com Australia

May 19, 2025

Iterum Therapeutics Plc (ITRM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):